Iranian researchers aimed to evaluate the effect of L-carnitine administration on atrial fibrillation, a common complication in patients undergoing coronary bypass surgery. Additionally, an inflammation marker (CRP) and the incidence of kidney injury after surgery were assessed. 134 patients were involved and assigned to a supplementation group, receiving 3000 mg of L-carnitine per day, or an untreated control group. The study showed that L-carnitine administration before coronary bypass surgery inhibited and reduced the incidence of atrial fibrillation after surgery. Furthermore, an increased CRP level, indicating an increased inflammation status associated with the incidence of atrial fibrillation, was reduced in the supplementation group. More details can be found in the study.
Dastan et al.